Roche Holding Ltd
RO · SIX · CHF
CHF 366.60
+5.60 1.55%todayNot financial advice.
- Open
- 364.80
- Day range
- 363.40 - 368.80
- 52-week range
- 270.80 - 383.00
- Volume
- 25.96K
- Market cap
- 343.36B
- P/E ratio
- 23.92
- EPS
- 19.18
- Dividend yield
- 2.95%
- Beta
- 1.21
Performance
W
+3.09%
1M
+2.46%
3M
+7.07%
6M
+11.23%
YTD
+9.50%
Y
+20.20%
5Y
−6.00%
All
+161.86%
In the news
Oct 10
Roche Unit Genentech Reports Positive Phase III Vamikibart Data as FDA Accepts Filing
Genentech presented 52-week Phase III vamikibart trial data as the FDA accepted its application for the potential non-steroid vision loss treatment.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/SIX-RO" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Roche Holding Ltd (RO) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/SIX-RO">RO stock price</a> by FreeTheAI Stocks</p>